06/2026 Provision of Services for the Conduct of Neuroautoimmune Tests of the Neuroimmunology Laboratory of the Diagnostic Department of E.I.P.
06/2026 Παροχή Υπηρεσιών για τη διενέργεια Nευροαυτοάνοσων εξετάσεων του εργαστηρίου Νευροανοσολογίας του Διαγνωστικού Τμήματος του Ε.Ι.Π.
Greece · Αθήνα · how to bid here →
Your path to submission
- Deadline: 5 November at 11:00 — 33 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: ELL, ELL, ELL, ELL.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (9 awards, most recently December 2025) — by that rhythm the next award was due around February 2026. The last award went to IN VITRO LABS Α.Ε..n = 9
- 73% of this buyer's awards went to companies that had already won here before (817 awards since 2023, spread over 225 companies). That is well above the sector norm (56%) — newcomers have a harder time here than elsewhere.n = 817 awards since 2023
- The median procedure drew just one bid (326 procedures with a bid count); 77% ended with a single bidder. Sector: median 1 bids.n = 326
- 1% of awards went to companies from abroad (817 awards with a known winner country). Sector average: 1%.n = 817
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 03/10/2026.
Foreign bidders
In Greece · Health & social work, 64 contracts went to foreign companies over the last 3 years (of 10,878 recorded awards) — mostly from Germany, Italy, Belgium.
Submission language: ELL.
Typical field: median 1 (from 4 awards).
What the buyer is looking for
Provision of services for the detection of antibodies against antigens: LGI1, CASPR2, NMDA receptor, AMPA receptors (GluR1, GluR2) GABAB receptors, GAD65, Hu (neurone nuclei; ANNA-1), Ri (neurone nuclei; ANNA-2), Yo (Purkinje cell cytoplasm; PCA-1) Amphiphysin, CV2 (CRMP-5), Ma1/Ma2 (neurone nucleoli; Ta), ANNA-3, PCA-2 (Purkinje cell cytoplasm), Tr (DNER), ZIC4, IgLON5, AGNA (anti-glia nuclear antigen),Recoverin Aquaporin-4, MOG (myelin-oligodendrocyte glycoprotein), Glycin receptors, DPPX, ITPR1 CARPVIII, Flotillin ½, mGluR1, mGluR5, Myelin MBP (myelin-basic protein), MAG (myelin-associated glycoprotein), GFAP (glial fibrillary acidic protein), Basal ganglia AT1A3, Contactin1, Dop. rec. 2 (DRD2), ERC1, GABA-a receptors, GluRD2, Homer3 KCNA2, Neurexin, Neurochondrin, Neurofascin (NF155/NF186), RhoGTpase-activating protein 26; SECTION 2 Provision of services for the detection of…
Show full description
… antibodies against LRP4 antigens; SECTION 3 Provision of services for the detection of antibodies against: MuSK protein, calcium channel surfactants (VGCC), potassium channel surfactants (VGKC); SECTION 4Supply of services for the detection of antibodies against antigens: Hu (neurone nuclei; ANNA-1), Ri (neurone nuclei; ANNA-2), Yo (Purkinje cell cytoplasm; PCA-1) Amphiphysin, CV2 (CRMP-5), Ma1/Ma2 (neurone nucleoli; Ta)
Selection criteria — not structured in the notice
The buyer left the criteria block of the EU form empty; the eligibility requirements are in the tender documents. The document analysis below extracts them from there — bid and evidence in Greek.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| ΑΦΟΙ Α. ΣΕΛΙΔΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ ΕΠΙΣΤΗΜΟΝΙΚΟΥ ΕΞΟΠΛΙΣΜΟΥ | 37 | 2024–2026 |
| LAB SUPPLIES-Π. ΓΑΛΑΝΗΣ ΚΑΙ ΣΙΑ Ο.Ε. | 35 | 2024–2026 |
| ΜΑΓΕΙΡΑΣ ΔΙΑΓΝΩΣΤΙΚΑ ΜΗΧΑΝΗΜΑΤΑ Α.Ε. | 26 | 2024–2026 |
| BIOANALYTICA ΕΜΠΟΡΙΚΗ ΒΙΟΤΕΧΝΟΛΟΓΙΚΩΝ ΕΦΑΡΜΟΓΩΝ - ΕΡΕΥΝΗΤΙΚΗ ΑΕ | 26 | 2024–2026 |
| NYBBLE Α.Ε. | 21 | 2024–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.